Oligonucleotide API Market 2022 Nā mea pāʻani koʻikoʻi, SWOT Analysis, Key Indicators and Forecast to 2030

Wahi a FMI - kahi hui noiʻi mākeke i hōʻoia ʻia e ESOMAR, ua manaʻo ʻia ka mākeke oligonucleotide API honua e hōʻea i $ 3 Bn i 2020, a ʻike i kahi CAGR o 11% ma 2030.

No ka loaʻa ʻana o kahi laʻana kope o ka hōʻike kipa @  https://www.futuremarketinsights.com/reports/sample/rep-gb-11933

Wahi a ka loiloi a FMI, i kēia manawa, aia nā 100+ oligonucleotide API i ka pae hoʻokolohua lapaʻau, a aia ka ʻae hoʻoponopono ma nā kāleka. Ma hope o ka ʻae ʻana, e ʻike ke koi no ka hiki ke hana i kahi exponentia, a laila e alakaʻi ana i ka mākeke API oligonucleotide ma 2030.

Ke nānā ʻia nei nā Oligonucleotides ma ke ʻano he hui nui o nā lāʻau lapaʻau e pili ana i nā biologics a me nā mole. Hiki ke hoʻopili ʻia kēia i ka ʻoiaʻiʻo o kā lākou ʻaoʻao e hoʻomohala i nā lāʻau lapaʻau ma nā kumukūʻai haʻahaʻa.

Ma waho aʻe o ka mālama kino, ka microbial a me ka maʻi cardiovascular, a me ka maʻi kanesa, ke hoʻāʻo ʻia nei nā API oligonucleotide e mālama i nā maʻi neurological e like me Alzheimer. Eia nō naʻe, ʻo nā mea e like me nā paʻakikī hoʻoponopono a me ka hāʻawi ʻana i ka manawa o ka oligonucleotides (i waena o Covid-19) ke hana nei i mea paʻa.

Nā mea nui i lawe ʻia mai ka Oligonucleotide API Marker Study

• Manaʻo ʻia nā API Antisense Oligonucleotides e hōʻea i ka US $ 4 Bn e 2030.
• ʻO ʻAmelika ʻĀkau a me ʻEulopa i hui pū ʻia ma mua o 47% o ka loaʻa kālā ma 2019 aʻo Asia Pacific e manaʻo ʻia e ulu i ka wikiwiki loa i ka wā wānana.
• Hoʻonui i ka hoʻohana ʻana i nā API oligonucleotide antisense (ʻoi aku ka ʻae ʻana mai ka US FDA ma 2016) e hoʻonui i ka mākeke i ka wā wānana

Hoʻokuʻu ʻia nā huahana hou: nā hōʻailona koʻikoʻi i ka mākeke oligonucleotide APIs

Ua loiloi ʻo FMI i nā mea pāʻani e like me Akcea Therapeutics, Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., a me Dynavax Technologies i kēia hōʻike. Wahi a ka loiloi, hoʻohui kēia mau mea pāʻani i ko lākou mau kūlana ma o ka hoʻokuʻu ʻana i nā huahana hou.

O kahi laʻana -

• I Malaki 2020, ua komo ʻo Dynavax i ka hui pū ʻana me Clover Biopharmaceuticals no ka hoʻomohala ʻana i kahi moho kano e hakakā ai iā Covid-19. Aia ʻo Clover i ka loiloi holomua o kāna Covid-19 S-Trimer, ka moho kano kano coronavirus e pili ana i ka protein a ua loaʻa iā Dynavax kāna ʻike loea me ka proprietary toll-like receptor 9 (TLR9) agonist adjuvant, CpG 1018 no ka hoʻokō ʻana i kēia.
• ʻO Alnylam Pharmaceuticals, Inc., ma 2018, ua hoʻokuʻu iā Givlaari a me Onpattro ma ka pae kalepa.

"ʻO ke ʻano o ka ulu ʻana i hui pū ʻia me nā noi therapeutic ākea ma hoʻōla gen manaʻo ʻia e hoʻoikaika i ka mākeke API oligonucleotide" wahi a ka mea loiloi FMI.

E noi i kahi mea kālailai @ https://www.futuremarketinsights.com/ask-question/rep-gb-11933

Gene Therapy a me Oligonucleotide API

Hoʻohana ʻia nā oligonucleotides synthetic i ka lāʻau lapaʻau no ka hoʻopau ʻana i nā genes e kōkua i ka hoʻolaha ʻana i ka maʻi. Hoʻohana ʻia nā API oligonucleotide antisense no ka hoʻopau ʻana i ka transcription o ka gene hewa.

Eia kekahi, hiki ke hoʻohana ʻia ʻo siRNA no ka hōʻailona ʻana i ke kelepona e hoʻopau i ka unuhi hewa ʻana o ka mRNA. Ma kēia mau laina, ua kau inoa ʻo Pharmamar, i Jan 2020, i ʻaelike me Jazz Pharmaceuticals no ke kūʻai aku ʻana i ka API no ka "lurbinectedin", kekahi o nā lāʻau lapaʻau hope loa no SCLC (small cell lung cancer cancer) i hiki i ka mea hope ke kūʻai aku.

Makemake ʻoe i nā ʻike hou aʻe?

Hāʻawi ka haʻawina i nā ʻike koʻikoʻi e pili ana i ka mākeke API Oligonucleotide ma ke kumu o ke ʻano API i ka kikoʻī e uhi i nā ʻāpana āpau o ka mākeke e like me Antisense Oligonucleotides API, Short Interfering RNA (siRNA) API, Phosphorodiamidate Morpholino Oligonucleotides (PMO) API, MiRNA API, Aptamers API, CpG Oligonucleotides API a me nā mea ʻē aʻe (ON Conjugates (NP), ShRNA, etc.), Kūlana Kūʻai (Marketed, Clinical Trials (Clinical Phases)), a me nā mea hoʻohana hope (Pharmaceutical Companies and Biotechnology Companies)) ma waena o ʻehiku mau wahi nui.

E nānā i ka hōʻike piha ma:  https://www.futuremarketinsights.com/reports/oligonucleotide-api-market